Unmet Clinical Needs in Polycythemia Vera

Ruben A. Mesa, MD

Video Categories: Polycythemia Vera

Dr. Mesa discusses what approaches in therapy he takes for PV patients with unmet clinical needs such as recurrent vascular events.

Supported through funding from Incyte
July 25, 2018

The Most Important Advances in Precision Medicine Being Presented at ASCO 2018

Dr David Spigel reviews 3 of the most important, practice-changing topics at ASCO 2018: new therapies targeting RET in a number of tumor types, a prognostic biomarker assay to predict whether patients with breast cancer will need adjuvant hormonal therapy or chemotherapy, and the minimum level of PD-L1 positivity required [ Read More ]

July 17, 2018

How the Treatment of Lung Cancer Has Been Transformed in the Era of Molecular Biomarker Testing

Drs Roy Herbst and David Rimm review how biomarker testing has transformed the way patients with lung cancer are treated, and how both medical oncologists and pathologists contribute to these changes.